The global Hyperimmune Globulins market is projected to reach US$ 2733.7 million by 2030 from an estimated US$ 1821.6 million in 2024, at a CAGR of 7.0% during 2024 and 2030.

Hyperimmune Globulins Market

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Global Hyperimmune Globulins key players include CSL Behring, Grifols, etc. Global top two manufacturers hold a share over 50%.

Asia-Pacific is the largest market, with a share about 30%, followed by Europe and North America, both have a share over 50 percent.

In terms of product, Rho(D) Immunoglobulins is the largest segment, with a share about 33%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hyperimmune Globulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Hyperimmune Globulins.

The Hyperimmune Globulins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hyperimmune Globulins market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hyperimmune Globulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

Market Segmentation

Scope of Hyperimmune Globulins Market Report

Report Metric	Details
Report Name	Hyperimmune Globulins Market
Accounted market size in 2024	an estimated US$ 1821.6 million
Forecasted market size in 2030	US$ 2733.7 million
CAGR	7.0%
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Hepatitis B Immunoglobulins Rabies Immunoglobulins Tetanus Immunoglobulins Rho(D) Immunoglobulins Other
Segment by Application	Government Institutions Private Sector Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hyperimmune Globulins in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Hyperimmune Globulins manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hyperimmune Globulins sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Hyperimmune Globulins Market growing?

Ans: The Hyperimmune Globulins Market witnessing a CAGR of 7.0% during the forecast period 2024-2030.

What is the Hyperimmune Globulins Market size in 2030?

Ans: The Hyperimmune Globulins Market size in 2030 will be US$ 2733.7 million.

What is the market share of major companies in Hyperimmune Globulins Market?

Ans: Global top two manufacturers hold a share over 50%.

Who are the main players in the Hyperimmune Globulins Market report?

Ans: The main players in the Hyperimmune Globulins Market are CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics

What are the Application segmentation covered in the Hyperimmune Globulins Market report?

Ans: The Applications covered in the Hyperimmune Globulins Market report are Government Institutions, Private Sector, Other

What are the Type segmentation covered in the Hyperimmune Globulins Market report?

Ans: The Types covered in the Hyperimmune Globulins Market report are Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Rho(D) Immunoglobulins, Other

1 Study Coverage

1.1 Hyperimmune Globulins Product Introduction

1.2 Market by Type

1.2.1 Global Hyperimmune Globulins Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Hepatitis B Immunoglobulins

1.2.3 Rabies Immunoglobulins

1.2.4 Tetanus Immunoglobulins

1.2.5 Rho(D) Immunoglobulins

1.2.6 Other

1.3 Market by Application

1.3.1 Global Hyperimmune Globulins Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Government Institutions

1.3.3 Private Sector

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Hyperimmune Globulins Market Size Estimates and Forecasts

2.1.1 Global Hyperimmune Globulins Revenue 2019-2030

2.1.2 Global Hyperimmune Globulins Sales 2019-2030

2.2 Hyperimmune Globulins Market Size by Region: 2023 Versus 2030

2.3 Hyperimmune Globulins Sales by Region (2019-2030)

2.3.1 Global Hyperimmune Globulins Sales by Region: 2019-2024

2.3.2 Global Hyperimmune Globulins Sales Forecast by Region (2025-2030)

2.3.3 Global Hyperimmune Globulins Sales Market Share by Region (2019-2030)

2.4 Hyperimmune Globulins Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Hyperimmune Globulins Revenue by Region: 2019-2024

2.4.2 Global Hyperimmune Globulins Revenue Forecast by Region (2025-2030)

2.4.3 Global Hyperimmune Globulins Revenue Market Share by Region (2019-2030)

3 Global Hyperimmune Globulins by Manufacturers

3.1 Global Top Hyperimmune Globulins Manufacturers by Sales

3.1.1 Global Hyperimmune Globulins Sales by Manufacturer (2019-2024)

3.1.2 Global Hyperimmune Globulins Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Hyperimmune Globulins Manufacturers by Revenue

3.2.1 Global Hyperimmune Globulins Revenue by Manufacturer (2019-2024)

3.2.2 Global Hyperimmune Globulins Revenue Share by Manufacturer (2019-2024)

3.3 Global Hyperimmune Globulins Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Hyperimmune Globulins Manufacturers Covered: Ranking by Revenue

3.4.2 Global Hyperimmune Globulins Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Hyperimmune Globulins Manufacturing Base Distribution, Product Type

3.5.1 Hyperimmune Globulins Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Hyperimmune Globulins Product Type

3.5.3 Date of International Manufacturers Enter into Hyperimmune Globulins Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 CSL Behring

4.1.1 CSL Behring Company Information

4.1.2 CSL Behring Description, Business Overview

4.1.3 CSL Behring Hyperimmune Globulins Products Offered

4.1.4 CSL Behring Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.1.5 CSL Behring Hyperimmune Globulins Sales by Product in 2023

4.1.6 CSL Behring Hyperimmune Globulins Sales by Application in 2023

4.1.7 CSL Behring Hyperimmune Globulins Sales by Geographic Area in 2023

4.1.8 CSL Behring Recent Developments

4.2 Grifols

4.2.1 Grifols Company Information

4.2.2 Grifols Description, Business Overview

4.2.3 Grifols Hyperimmune Globulins Products Offered

4.2.4 Grifols Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.2.5 Grifols Hyperimmune Globulins Sales by Product in 2023

4.2.6 Grifols Hyperimmune Globulins Sales by Application in 2023

4.2.7 Grifols Hyperimmune Globulins Sales by Geographic Area in 2023

4.2.8 Grifols Recent Developments

4.3 Biotest

4.3.1 Biotest Company Information

4.3.2 Biotest Description, Business Overview

4.3.3 Biotest Hyperimmune Globulins Products Offered

4.3.4 Biotest Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.3.5 Biotest Hyperimmune Globulins Sales by Product in 2023

4.3.6 Biotest Hyperimmune Globulins Sales by Application in 2023

4.3.7 Biotest Hyperimmune Globulins Sales by Geographic Area in 2023

4.3.8 Biotest Recent Developments

4.4 Kedrion

4.4.1 Kedrion Company Information

4.4.2 Kedrion Description, Business Overview

4.4.3 Kedrion Hyperimmune Globulins Products Offered

4.4.4 Kedrion Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Kedrion Hyperimmune Globulins Sales by Product in 2023

4.4.6 Kedrion Hyperimmune Globulins Sales by Application in 2023

4.4.7 Kedrion Hyperimmune Globulins Sales by Geographic Area in 2023

4.4.8 Kedrion Recent Developments

4.5 CBPO

4.5.1 CBPO Company Information

4.5.2 CBPO Description, Business Overview

4.5.3 CBPO Hyperimmune Globulins Products Offered

4.5.4 CBPO Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.5.5 CBPO Hyperimmune Globulins Sales by Product in 2023

4.5.6 CBPO Hyperimmune Globulins Sales by Application in 2023

4.5.7 CBPO Hyperimmune Globulins Sales by Geographic Area in 2023

4.5.8 CBPO Recent Developments

4.6 Emergent (Cangene)

4.6.1 Emergent (Cangene) Company Information

4.6.2 Emergent (Cangene) Description, Business Overview

4.6.3 Emergent (Cangene) Hyperimmune Globulins Products Offered

4.6.4 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.6.5 Emergent (Cangene) Hyperimmune Globulins Sales by Product in 2023

4.6.6 Emergent (Cangene) Hyperimmune Globulins Sales by Application in 2023

4.6.7 Emergent (Cangene) Hyperimmune Globulins Sales by Geographic Area in 2023

4.6.8 Emergent (Cangene) Recent Development

4.7 Kamada

4.7.1 Kamada Company Information

4.7.2 Kamada Description, Business Overview

4.7.3 Kamada Hyperimmune Globulins Products Offered

4.7.4 Kamada Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.7.5 Kamada Hyperimmune Globulins Sales by Product in 2023

4.7.6 Kamada Hyperimmune Globulins Sales by Application in 2023

4.7.7 Kamada Hyperimmune Globulins Sales by Geographic Area in 2023

4.7.8 Kamada Recent Development

4.8 CNBG

4.8.1 CNBG Company Information

4.8.2 CNBG Description, Business Overview

4.8.3 CNBG Hyperimmune Globulins Products Offered

4.8.4 CNBG Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.8.5 CNBG Hyperimmune Globulins Sales by Product in 2023

4.8.6 CNBG Hyperimmune Globulins Sales by Application in 2023

4.8.7 CNBG Hyperimmune Globulins Sales by Geographic Area in 2023

4.8.8 CNBG Recent Development

4.9 Hualan Bio

4.9.1 Hualan Bio Company Information

4.9.2 Hualan Bio Description, Business Overview

4.9.3 Hualan Bio Hyperimmune Globulins Products Offered

4.9.4 Hualan Bio Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.9.5 Hualan Bio Hyperimmune Globulins Sales by Product in 2023

4.9.6 Hualan Bio Hyperimmune Globulins Sales by Application in 2023

4.9.7 Hualan Bio Hyperimmune Globulins Sales by Geographic Area in 2023

4.9.8 Hualan Bio Recent Development

4.10 Shanghai RAAS

4.10.1 Shanghai RAAS Company Information

4.10.2 Shanghai RAAS Description, Business Overview

4.10.3 Shanghai RAAS Hyperimmune Globulins Products Offered

4.10.4 Shanghai RAAS Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.10.5 Shanghai RAAS Hyperimmune Globulins Sales by Product in 2023

4.10.6 Shanghai RAAS Hyperimmune Globulins Sales by Application in 2023

4.10.7 Shanghai RAAS Hyperimmune Globulins Sales by Geographic Area in 2023

4.10.8 Shanghai RAAS Recent Development

4.11 Sichuan Yuanda Shuyang

4.11.1 Sichuan Yuanda Shuyang Company Information

4.11.2 Sichuan Yuanda Shuyang Description, Business Overview

4.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Products Offered

4.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.11.5 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales by Product in 2023

4.11.6 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales by Application in 2023

4.11.7 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales by Geographic Area in 2023

4.11.8 Sichuan Yuanda Shuyang Recent Development

4.12 ADMA Biologics

4.12.1 ADMA Biologics Company Information

4.12.2 ADMA Biologics Description, Business Overview

4.12.3 ADMA Biologics Hyperimmune Globulins Products Offered

4.12.4 ADMA Biologics Hyperimmune Globulins Sales, Revenue and Gross Margin (2019-2024)

4.12.5 ADMA Biologics Hyperimmune Globulins Sales by Product in 2023

4.12.6 ADMA Biologics Hyperimmune Globulins Sales by Application in 2023

4.12.7 ADMA Biologics Hyperimmune Globulins Sales by Geographic Area in 2023

4.12.8 ADMA Biologics Recent Development

5 Breakdown Data by Type

5.1 Global Hyperimmune Globulins Sales by Type (2019-2030)

5.1.1 Global Hyperimmune Globulins Sales by Type (2019-2024)

5.1.2 Global Hyperimmune Globulins Sales Forecast by Type (2025-2030)

5.1.3 Global Hyperimmune Globulins Sales Market Share by Type (2019-2030)

5.2 Global Hyperimmune Globulins Revenue Forecast by Type (2019-2030)

5.2.1 Global Hyperimmune Globulins Revenue by Type (2019-2024)

5.2.2 Global Hyperimmune Globulins Revenue Forecast by Type (2025-2030)

5.2.3 Global Hyperimmune Globulins Revenue Market Share by Type (2019-2030)

5.3 Hyperimmune Globulins Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Hyperimmune Globulins Sales by Application (2019-2030)

6.1.1 Global Hyperimmune Globulins Sales by Application (2019-2024)

6.1.2 Global Hyperimmune Globulins Sales Forecast by Application (2025-2030)

6.1.3 Global Hyperimmune Globulins Sales Market Share by Application (2019-2030)

6.2 Global Hyperimmune Globulins Revenue Forecast by Application (2019-2030)

6.2.1 Global Hyperimmune Globulins Revenue by Application (2019-2024)

6.2.2 Global Hyperimmune Globulins Revenue Forecast by Application (2025-2030)

6.2.3 Global Hyperimmune Globulins Revenue Market Share by Application (2019-2030)

6.3 Hyperimmune Globulins Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Hyperimmune Globulins Market Size YoY Growth 2019-2030

7.2 North America Hyperimmune Globulins Market Facts & Figures by Country

7.2.1 North America Hyperimmune Globulins Sales by Country (2019-2030)

7.2.2 North America Hyperimmune Globulins Revenue by Country (2019-2030)

7.3 North America Hyperimmune Globulins Sales by Type (2019-2024)

7.4 North America Hyperimmune Globulins Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Hyperimmune Globulins Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Hyperimmune Globulins Market Facts & Figures by Region

8.2.1 Asia-Pacific Hyperimmune Globulins Sales by Region (2019-2030)

8.2.2 Asia-Pacific Hyperimmune Globulins Revenue by Region (2019-2030)

8.3 Asia-Pacific Hyperimmune Globulins Sales by Type (2019-2024)

8.4 Asia-Pacific Hyperimmune Globulins Sales by Application (2019-2024)

9 Europe

9.1 Europe Hyperimmune Globulins Market Size YoY Growth 2019-2030

9.2 Europe Hyperimmune Globulins Market Facts & Figures by Country

9.2.1 Europe Hyperimmune Globulins Sales by Country (2019-2030)

9.2.2 Europe Hyperimmune Globulins Revenue by Country (2019-2030)

9.3 Europe Hyperimmune Globulins Sales by Type (2019-2024)

9.4 Europe Hyperimmune Globulins Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Hyperimmune Globulins Market Size YoY Growth 2019-2030

10.2 Latin America Hyperimmune Globulins Market Facts & Figures by Country

10.2.1 Latin America Hyperimmune Globulins Sales by Country (2019-2030)

10.2.2 Latin America Hyperimmune Globulins Revenue by Country (2019-2030)

10.3 Latin America Hyperimmune Globulins Sales by Type (2019-2024)

10.4 Latin America Hyperimmune Globulins Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Hyperimmune Globulins Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Hyperimmune Globulins Market Facts & Figures by Country

11.2.1 Middle East and Africa Hyperimmune Globulins Sales by Country (2019-2030)

11.2.2 Middle East and Africa Hyperimmune Globulins Revenue by Country (2019-2030)

11.3 Middle East and Africa Hyperimmune Globulins Sales by Type (2019-2024)

11.4 Middle East and Africa Hyperimmune Globulins Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Hyperimmune Globulins Supply Chain Analysis

12.2 Hyperimmune Globulins Key Raw Materials and Upstream Suppliers

12.3 Hyperimmune Globulins Clients Analysis

12.4 Hyperimmune Globulins Sales Channel and Sales Model Analysis

12.4.1 Hyperimmune Globulins Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Hyperimmune Globulins Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Hyperimmune Globulins Distributors

13 Market Dynamics

13.1 Hyperimmune Globulins Industry Trends

13.2 Hyperimmune Globulins Market Drivers

13.3 Hyperimmune Globulins Market Challenges

13.4 Hyperimmune Globulins Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Sichuan Yuanda Shuyang

ADMA Biologics

List of Tables

Table 1. Global Hyperimmune Globulins Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of Hepatitis B Immunoglobulins

Table 3. Major Manufacturers of Rabies Immunoglobulins

Table 4. Major Manufacturers of Tetanus Immunoglobulins

Table 5. Major Manufacturers of Rho(D) Immunoglobulins

Table 6. Major Manufacturers of Other

Table 7. Global Hyperimmune Globulins Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Hyperimmune Globulins Market Size by Region (US$ Million): 2023 VS 2030

Table 9. Global Hyperimmune Globulins Sales by Region (2019-2024) & (K Units)

Table 10. Global Hyperimmune Globulins Sales Forecast by Region (2025-2030) & (K Units)

Table 11. Global Hyperimmune Globulins Revenue by Region (2019-2024) & (US$ Million)

Table 12. Global Hyperimmune Globulins Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 13. Global Hyperimmune Globulins Sales by Manufacturer (2019-2024) & (K Units)

Table 14. Global Hyperimmune Globulins Sales Share by Manufacturer (2019-2024)

Table 15. Hyperimmune Globulins Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 16. Hyperimmune Globulins Revenue Share by Manufacturer (2019-2024)

Table 17. Key Manufacturers Hyperimmune Globulins Price (2019-2024) & (USD/Unit)

Table 18. Ranking of Global Top Hyperimmune Globulins Manufacturers by Revenue (US$ Million) in 2023

Table 19. Global Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 20. Global Hyperimmune Globulins by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2023)

Table 21. Hyperimmune Globulins Manufacturers Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Hyperimmune Globulins Product Type

Table 23. Date of International Manufacturers Enter into Hyperimmune Globulins Market

Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 25. CSL Behring Company Information

Table 26. CSL Behring Description and Business Overview

Table 27. CSL Behring Hyperimmune Globulins Product

Table 28. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 29. CSL Behring Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 30. CSL Behring Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 31. CSL Behring Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 32. CSL Behring Recent Development

Table 33. Grifols Company Information

Table 34. Grifols Description and Business Overview

Table 35. Grifols Hyperimmune Globulins Product

Table 36. Grifols Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 37. Grifols Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 38. Grifols Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 39. Grifols Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 40. Grifols Recent Development

Table 41. Biotest Company Information

Table 42. Biotest Description and Business Overview

Table 43. Biotest Hyperimmune Globulins Product

Table 44. Biotest Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 45. Biotest Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 46. Biotest Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 47. Biotest Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 48. Biotest Recent Development

Table 49. Kedrion Company Information

Table 50. Kedrion Description and Business Overview

Table 51. Kedrion Hyperimmune Globulins Product

Table 52. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 53. Kedrion Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 54. Kedrion Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 55. Kedrion Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 56. Kedrion Recent Development

Table 57. CBPO Company Information

Table 58. CBPO Description and Business Overview

Table 59. CBPO Hyperimmune Globulins Product

Table 60. CBPO Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 61. CBPO Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 62. CBPO Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 63. CBPO Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 64. CBPO Recent Development

Table 65. Emergent (Cangene) Company Information

Table 66. Emergent (Cangene) Description and Business Overview

Table 67. Emergent (Cangene) Hyperimmune Globulins Product

Table 68. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 69. Emergent (Cangene) Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 70. Emergent (Cangene) Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 71. Emergent (Cangene) Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 72. Emergent (Cangene) Recent Development

Table 73. Kamada Company Information

Table 74. Kamada Description and Business Overview

Table 75. Kamada Hyperimmune Globulins Product

Table 76. Kamada Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 77. Kamada Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 78. Kamada Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 79. Kamada Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 80. Kamada Recent Development

Table 81. CNBG Company Information

Table 82. CNBG Description and Business Overview

Table 83. CNBG Hyperimmune Globulins Product

Table 84. CNBG Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. CNBG Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 86. CNBG Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 87. CNBG Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 88. CNBG Recent Development

Table 89. Hualan Bio Company Information

Table 90. Hualan Bio Description and Business Overview

Table 91. Hualan Bio Hyperimmune Globulins Product

Table 92. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Hualan Bio Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 94. Hualan Bio Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 95. Hualan Bio Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 96. Hualan Bio Recent Development

Table 97. Shanghai RAAS Company Information

Table 98. Shanghai RAAS Description and Business Overview

Table 99. Shanghai RAAS Hyperimmune Globulins Product

Table 100. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 101. Shanghai RAAS Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 102. Shanghai RAAS Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 103. Shanghai RAAS Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 104. Shanghai RAAS Recent Development

Table 105. Sichuan Yuanda Shuyang Company Information

Table 106. Sichuan Yuanda Shuyang Description and Business Overview

Table 107. Sichuan Yuanda Shuyang Hyperimmune Globulins Product

Table 108. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 109. Sichuan Yuanda Shuyang Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 110. Sichuan Yuanda Shuyang Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 111. Sichuan Yuanda Shuyang Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 112. Sichuan Yuanda Shuyang Recent Development

Table 113. ADMA Biologics Company Information

Table 114. ADMA Biologics Description and Business Overview

Table 115. ADMA Biologics Hyperimmune Globulins Product

Table 116. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 117. ADMA Biologics Sales Proportion of Hyperimmune Globulins by Product in 2023

Table 118. ADMA Biologics Sales Proportion of Hyperimmune Globulins by Application in 2023

Table 119. ADMA Biologics Sales Proportion of Hyperimmune Globulins by Geographic Area in 2023

Table 120. ADMA Biologics Recent Development

Table 121. Global Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)

Table 122. Global Hyperimmune Globulins Sales Forecast by Type (2025-2030) & (K Units)

Table 123. Global Hyperimmune Globulins Revenue by Type (2019-2024) & (US$ Million)

Table 124. Global Hyperimmune Globulins Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 125. Global Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)

Table 126. Global Hyperimmune Globulins Sales Forecast by Application (2025-2030) & (K Units)

Table 127. Global Hyperimmune Globulins Revenue by Application (2019-2024) & (US$ Million)

Table 128. Global Hyperimmune Globulins Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 129. North America Hyperimmune Globulins Sales by Country (2019-2024) & (K Units)

Table 130. North America Hyperimmune Globulins Sales by Country (2025-2030) & (K Units)

Table 131. North America Hyperimmune Globulins Revenue by Country (2019-2024) & (US$ Million)

Table 132. North America Hyperimmune Globulins Revenue by Country (2025-2030) & (US$ Million)

Table 133. North America Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)

Table 134. North America Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)

Table 135. Asia-Pacific Hyperimmune Globulins Sales by Region (2019-2024) & (K Units)

Table 136. Asia-Pacific Hyperimmune Globulins Sales by Region (2025-2030) & (K Units)

Table 137. Asia-Pacific Hyperimmune Globulins Revenue by Region (2019-2030) & (US$ Million)

Table 138. Asia-Pacific Hyperimmune Globulins Revenue by Region (2025-2030) & (US$ Million)

Table 139. Asia-Pacific Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)

Table 140. Asia-Pacific Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)

Table 141. Europe Hyperimmune Globulins Sales by Country (2019-2024) & (K Units)

Table 142. Europe Hyperimmune Globulins Sales by Country (2025-2030) & (K Units)

Table 143. Europe Hyperimmune Globulins Revenue by Country (2019-2024) & (US$ Million)

Table 144. Europe Hyperimmune Globulins Revenue by Country (2025-2030) & (US$ Million)

Table 145. Europe Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)

Table 146. Europe Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)

Table 147. Latin America Hyperimmune Globulins Sales by Country (2019-2024) & (K Units)

Table 148. Latin America Hyperimmune Globulins Sales by Country (2025-2030) & (K Units)

Table 149. Latin America Hyperimmune Globulins Revenue by Country (2019-2024) & (US$ Million)

Table 150. Latin America Hyperimmune Globulins Revenue by Country (2025-2030) & (US$ Million)

Table 151. Latin America Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)

Table 152. Latin America Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)

Table 153. Middle East and Africa Hyperimmune Globulins Sales by Country (2019-2024) & (K Units)

Table 154. Middle East and Africa Hyperimmune Globulins Sales by Country (2025-2030) & (K Units)

Table 155. Middle East and Africa Hyperimmune Globulins Revenue by Country (2019-2024) & (US$ Million)

Table 156. Middle East and Africa Hyperimmune Globulins Revenue by Country (2025-2030) & (US$ Million)

Table 157. Middle East and Africa Hyperimmune Globulins Sales by Type (2019-2024) & (K Units)

Table 158. Middle East and Africa Hyperimmune Globulins Sales by Application (2019-2024) & (K Units)

Table 159. Hyperimmune Globulins Key Raw Materials, Industry Status and Trend

Table 160. Hyperimmune Globulins Key Raw Materials and Upstream Suppliers

Table 161. Hyperimmune Globulins Clients Status and Trend

Table 162. Hyperimmune Globulins Typical Clients

Table 163. Hyperimmune Globulins Distributors

Table 164. Hyperimmune Globulins Market Trends

Table 165. Hyperimmune Globulins Market Drivers

Table 166. Hyperimmune Globulins Market Challenges

Table 167. Hyperimmune Globulins Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Hyperimmune Globulins Product Picture

Figure 2. Global Hyperimmune Globulins Sales Market Share by Type in 2023 & 2030

Figure 3. Hepatitis B Immunoglobulins Product Picture

Figure 4. Rabies Immunoglobulins Product Picture

Figure 5. Tetanus Immunoglobulins Product Picture

Figure 6. Rho(D) Immunoglobulins Product Picture

Figure 7. Other Product Picture

Figure 8. Global Hyperimmune Globulins Sales Market Share by Application in 2023 & 2030

Figure 9. Government Institutions Examples

Figure 10. Private Sector Examples

Figure 11. Other Examples

Figure 12. Hyperimmune Globulins Report Years Considered

Figure 13. Global Hyperimmune Globulins Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Hyperimmune Globulins Market Size 2019-2030 (US$ Million)

Figure 15. Global Hyperimmune Globulins Sales 2019-2030 (K Units)

Figure 16. Global Hyperimmune Globulins Sales Market Share Forecast by Region (2019-2030)

Figure 17. Global Hyperimmune Globulins Revenue Market Share by Region (2019-2030)

Figure 18. Global Hyperimmune Globulins Sales Share by Manufacturer in 2023

Figure 19. Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Hyperimmune Globulins Sales Market Share Forecast by Type (2019-2030)

Figure 21. Global Hyperimmune Globulins Revenue Market Share Forecast by Type (2019-2030)

Figure 22. Hyperimmune Globulins Average Selling Price (ASP) by Type (2019-2024) & (USD/Unit)

Figure 23. Global Hyperimmune Globulins Sales Market Share Forecast by Application (2019-2030)

Figure 24. Global Hyperimmune Globulins Revenue Market Share Forecast by Application (2019-2030)

Figure 25. Hyperimmune Globulins Average Selling Price (ASP) by Application (2019-2024) & (USD/Unit)

Figure 26. North America Hyperimmune Globulins Revenue 2019-2030 (US$ Million)

Figure 27. North America Hyperimmune Globulins Sales Market Share by Type (2019-2024)

Figure 28. North America Hyperimmune Globulins Sales Market Share by Application (2019-2024)

Figure 29. Asia-Pacific Hyperimmune Globulins Revenue 2019-2030 (US$ Million)

Figure 30. Asia-Pacific Hyperimmune Globulins Sales Market Share by Region (2019-2030)

Figure 31. Asia-Pacific Hyperimmune Globulins Revenue Market Share by Region (2019-2030)

Figure 32. Asia-Pacific Hyperimmune Globulins Sales Market Share by Type (2019-2024)

Figure 33. Asia-Pacific Hyperimmune Globulins Sales Market Share by Application (2019-2024)

Figure 34. Europe Hyperimmune Globulins Revenue Growth Rate 2019-2030 (US$ Million)

Figure 35. Europe Hyperimmune Globulins Sales Market Share by Country (2019-2030)

Figure 36. Europe Hyperimmune Globulins Revenue Market Share by Country (2019-2030)

Figure 37. Europe Hyperimmune Globulins Sales Market Share by Type (2019-2024)

Figure 38. Europe Hyperimmune Globulins Sales Market Share by Application (2019-2024)

Figure 39. Latin America Hyperimmune Globulins Revenue Growth Rate 2019-2030 (US$ Million)

Figure 40. Latin America Hyperimmune Globulins Sales Market Share by Country (2019-2030)

Figure 41. Latin America Hyperimmune Globulins Revenue Market Share by Country (2019-2024)

Figure 42. Latin America Hyperimmune Globulins Sales Market Share by Type (2019-2024)

Figure 43. Latin America Hyperimmune Globulins Sales Market Share by Application (2019-2024)

Figure 44. Middle East and Africa Hyperimmune Globulins Revenue Growth Rate 2019-2030 (US$ Million)

Figure 45. Middle East and Africa Hyperimmune Globulins Sales Market Share by Country (2019-2030)

Figure 46. Middle East and Africa Hyperimmune Globulins Revenue Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Hyperimmune Globulins Sales Market Share by Type (2019-2024)

Figure 48. Middle East and Africa Hyperimmune Globulins Sales Market Share by Application (2019-2024)

Figure 49. Hyperimmune Globulins Supply Chain (Upstream and Downstream Market)

Figure 50. Global Production Market Share of Hyperimmune Globulins Raw Materials by Region in 2023

Figure 51. Hyperimmune Globulins Distribution Channels

Figure 52. Global Hyperimmune Globulins Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 53. Global Hyperimmune Globulins Percentage 2019-2030: Online Sales VS Offline Sales

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Systemic Scleroderma Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7D5947

Wed Jul 24 00:00:00 UTC 2024

Add to Cart

Global Dermatology Drugs for Pets Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8J8253

Sat Jul 20 00:00:00 UTC 2024

Add to Cart

Global Ophthalmic Medicine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-13H8167

Sat Jul 20 00:00:00 UTC 2024

Add to Cart

Global Parasiticides for Swine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29H10454

Sat Jul 20 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions